RYDCX | RYVYX | RYDCX / RYVYX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 23 years | 24 years | - |
Gain YTD | 13.148 | 23.324 | 56% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 2500 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 13.4M | 941M | 1% |
Annual Yield % from dividends | 0.39 | 0.00 | - |
Returns for 1 year | 26.92 | 47.65 | 56% |
Returns for 3 years | -9.33 | 10.92 | -85% |
Returns for 5 years | 32.71 | 206.99 | 16% |
Returns for 10 years | 93.78 | 625.49 | 15% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LSHEX | 29.76 | 0.16 | +0.54% |
Kinetics Spin-Off and Corp Rest No Load | |||
FBTTX | 30.80 | 0.02 | +0.06% |
Fidelity Advisor Biotechnology M | |||
AMVGX | 17.04 | N/A | N/A |
American Century Mid Cap Value R5 | |||
MLNAX | 22.54 | -0.12 | -0.53% |
Morgan Stanley Instl Glbl Concntr A | |||
ROGSX | 46.79 | -0.29 | -0.62% |
Red Oak Technology Select |